Form 4 for RNXT RenovoRx, Inc.
Accepted 2025-04-16 00:00:00 ET · period of report 2025-04-15 · accession 0001641172-25-004955 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-16 | 2025-04-15 | RNXT | Bagai Shaun | CEO, Dir | P - Purchase | $0.91 | +7,500 | 320.0K | +2% | +$6,825 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-15 | P | A | 7,500 | $0.91 | 320,040 | D | — | — | (F1) Reflects open market purchases of the Issuer's securities. |